
1 

(1) This order may be cited as the Medicines (Cyanogenetic Substances) Order 1984 and shall come into operation on the tenth day after the day on which it is made.
(2) In this order—
 “the Act” means the Medicines Act 1968;
 “cyanogenetic substances” means preparations which—


(a) are presented for sale or supply under the name of, or as containing, amygdalin, laetrile or vitamin B17 or
(b) contain more than 0.1 per cent by weight of any substance having the formula either α-Cyanobenzyl-6-O-Β-D-glucopyranosyl-Β-D-glucopyranoside or α-Cyanobenzyl-Β-D-glucopyranosiduronic acid.
2 
For the purposes of section 104(1) of the Act, cyanogenetic substances which are intended for human consumption and are not manufactured, sold, supplied, imported or exported wholly or mainly in either of the ways specified in section 130(1) of the Act are hereby specified as substances which appear to the Health Ministers to be substances which are not medicinal products but which are manufactured, sold, supplied, imported or exported for use wholly or partly for a medicinal purpose and it is hereby directed that the provisions contained in Part I, sections 51, 52, 55(1), 57, 58, 61 to 67, 85 to 88, 91 to 93, 95 and 97 and Part VIII of the Act shall have effect in relation to such substances as those provisions have effect in relation to medicinal products.
Signed by authority of the Secretary of State for Social Services.
John Patten
Parliamentary Under-Secretary of State
Department of Health and Social Security
15th February 1984Nicholas Edwards
Secretary of State for Wales
17th February 1984George Younger
Secretary of State for Scotland
20th February 1984Sealed with the official seal of the Department of Health and Social Services for Northern Ireland this 17th day of February 1984.
Maurice N. Hayes
Permanent Secretary
